Bain Capital Public Equity Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-138,508
Closed -$29.1M 80
2016
Q4
$29.1M Sell
138,508
-406,593
-75% -$84.2M 1.97% 19
2016
Q3
$126M Sell
545,101
-308,575
-36% -$75.4M 8.14% 3
2016
Q2
$197M Buy
853,676
+74,331
+10% +$17.1M 8.27% 1
2016
Q1
$209M Sell
779,345
-173,006
-18% -$49.5M 7.76% 3
2015
Q4
$298M Buy
952,351
+647,461
+212% +$193M 8.54% 2
2015
Q3
$82.9M Buy
+304,890
New +$93.7M 2.47% 18

Other funds holding AGN

Bain Capital Public Equity Management's AGN Position: Q1 2017 in Review

Bain Capital Public Equity Management sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 138,508 shares — an estimated $29.1M sold.

Bain Capital Public Equity Management first reported a position in AGN in Q3 2015 and held it in 6 quarters. The position peaked at $298M in Q4 2015. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Bain Capital Public Equity Management reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Bain Capital Public Equity Management sold 138,508 Allergan plc shares in Q1 2017, an estimated $29.1M.
  • Bain Capital Public Equity Management first reported a position in Allergan plc in Q3 2015 and held it in 6 quarters.
  • Bain Capital Public Equity Management's Allergan plc position peaked at $298M in Q4 2015.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Bain Capital Public Equity Management's 13F filing for Q1 2017, filed 15 May 2017.